A detailed history of Private Capital Group, LLC transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Private Capital Group, LLC holds 325 shares of NUVB stock, worth $747. This represents 0.0% of its overall portfolio holdings.

Number of Shares
325
Previous 1,000 67.5%
Holding current value
$747
Previous $5,000 80.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 28, 2022

SELL
$3.24 - $5.85 $2,187 - $3,948
-675 Reduced 67.5%
325 $1,000
Q4 2021

Jan 24, 2022

BUY
$7.75 - $10.05 $7,750 - $10,050
1,000 New
1,000 $9,000

Others Institutions Holding NUVB

About Nuvation Bio Inc.


  • Ticker NUVB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 217,244,000
  • Market Cap $500M
  • Description
  • Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...
More about NUVB
Track This Portfolio

Track Private Capital Group, LLC Portfolio

Follow Private Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Capital Group, LLC with notifications on news.